Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 10/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26465830 | 0.83 | CACNA1H (0.73) | CACNA1HALDH1A1KDM4EPSMB5 | |
| SCHEMBL26463801 | 0.78 | CACNA1H (0.71) | CACNA1HALDH1A1KDM4E | |
| SCHEMBL26465831 | 0.75 | ALDH1A1 (0.50) | CACNA1HALDH1A1KDM4EPSMB5 | |
| SCHEMBL26466000 | 0.74 | CACNA1H (0.58) | CACNA1HALDH1A1KDM4E | |
| SCHEMBL26465834 | 0.73 | MEN1 (0.48) | CACNA1HALDH1A1KDM4EPSMB5EPHX1 | |
| SCHEMBL26466013 | 0.73 | CACNA1H (0.57) | CACNA1HALDH1A1KDM4E | |
| SCHEMBL26466010 | 0.73 | CACNA1H (0.57) | CACNA1HALDH1A1KDM4E | |
| SCHEMBL26498849 | 0.72 | CACNA1H (1.00) | CACNA1HALDH1A1KDM4EPSMB5EPHX1 | |
| SCHEMBL26465843 | 0.72 | ALDH1A1 (0.49) | CACNA1HALDH1A1KDM4EPSMB5EPHX1 | |
| SCHEMBL26466599 | 0.72 | CACNA1H (0.70) | CACNA1HALDH1A1KDM4EEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192669-A1 | T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF | PRAXIS PRECISION MEDICINES, INC. (US) | 2023-10-05 | — | — | WO | disclosed |